JPS63185970A - 2h-1,4-benzoxazin-3(4h)-one derivative - Google Patents

2h-1,4-benzoxazin-3(4h)-one derivative

Info

Publication number
JPS63185970A
JPS63185970A JP1437987A JP1437987A JPS63185970A JP S63185970 A JPS63185970 A JP S63185970A JP 1437987 A JP1437987 A JP 1437987A JP 1437987 A JP1437987 A JP 1437987A JP S63185970 A JPS63185970 A JP S63185970A
Authority
JP
Japan
Prior art keywords
iodo
group
formula
benzoxazin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1437987A
Other languages
Japanese (ja)
Inventor
Kenjiro Tanimura
谷村 健次郎
Koji Kosegi
小瀬木 幸司
Hajime Shimazu
島津 肇
Hideya Yaginuma
柳沼 英哉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MORISHITA SEIYAKU KK
Morishita Pharmaceuticals Co Ltd
Original Assignee
MORISHITA SEIYAKU KK
Morishita Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MORISHITA SEIYAKU KK, Morishita Pharmaceuticals Co Ltd filed Critical MORISHITA SEIYAKU KK
Priority to JP1437987A priority Critical patent/JPS63185970A/en
Publication of JPS63185970A publication Critical patent/JPS63185970A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:A 2H-1,4-benzoxazin-3(4H)-one derivative shown by formula I (R<1> is 3-iodo-2-propynyloxy or 3-iodo-2-propynyl; R<2> is H, halogen, lower alkyl, acyloxy or NO2). EXAMPLE:4-(3-Iodo-2-propynyloxy)-2H-1,4-benzoxazin-3(4H)-one. USE:An antifungal agent showing extremely strong antifungal activity effective for treating and preventing superficial mycosis. PREPARATION:A compound shown by formula II is reacted with 3-bromo-1- iodo-propyne or a compound shown by formula III is reacted with iodine in the presence of a base to give a compound shown by formula I (Ia, Ib).

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、極めて強い抗真菌活性を有し、表在性真菌症
の治療並びに予防に有用な2H−1,4−ベンズオキサ
ジン−3(4H)−オン誘導体に関するものである。
Detailed Description of the Invention [Industrial Application Field] The present invention provides 2H-1,4-benzoxazine-3 ( 4H)-one derivatives.

〔従来の技術〕[Conventional technology]

3−ヨード−2−プロピニル基を有するへロブロジン(
下記構造式で示される化合物)は、強力な抗真菌活性を
有し、水虫治療薬として臨床に供されている。
Herobrodin with 3-iodo-2-propynyl group (
The compound represented by the following structural formula) has strong antifungal activity and is used clinically as a treatment for athlete's foot.

〔発明が解決しよ・うとする問題点〕[Problem that the invention attempts to solve]

本発明者らは、3−ヨード−2−プロピニル基を有する
化合物を種々合成しその抗真菌活性を調べたところ、前
記ハロプロジンよりも・高い活性を示す一連の化合物を
見出し、本発明を完成した。
The present inventors synthesized various compounds having a 3-iodo-2-propynyl group and investigated their antifungal activity, and found a series of compounds exhibiting higher activity than the above-mentioned haloprozin, and completed the present invention. did.

〔問題点を解決するための手段、及び作用〕本発明は、
下記一般式(1)で表される化合物に係わる。
[Means and effects for solving the problems] The present invention has the following features:
It relates to a compound represented by the following general formula (1).

■ 〔式中、R1は3−ヨード−2−プロピニルオキシ基又
は3−ヨード−2−プロピニル基を示す。
(2) [In the formula, R1 represents a 3-iodo-2-propynyloxy group or a 3-iodo-2-propynyl group.

R2は水素原子、ハロゲン原子、低級アルキル基、アシ
ルオキシ基又はニトロ基を示す。〕一般式(1)におい
て、Rzに関し具体的には、水素原子、フッ素原子、塩
素原子、臭素原子、ヨウ素原子、メチル基、エチル基、
プロピル基、イソプロピル基、ブチル基、イソブチル5
.5ee−ブチル基、tert−ブチル基、アセチルオ
キシ基、プロピオニルオキシ基、ベンゾイルオキシ基、
ニド四基等を例示できる。
R2 represents a hydrogen atom, a halogen atom, a lower alkyl group, an acyloxy group or a nitro group. ] In general formula (1), Rz specifically includes a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group,
Propyl group, isopropyl group, butyl group, isobutyl 5
.. 5ee-butyl group, tert-butyl group, acetyloxy group, propionyloxy group, benzoyloxy group,
Examples include four Nido groups.

本発明化合物は、以下に示す〔反応式−1及び2〕の方
法より容易に製造できる。
The compounds of the present invention can be easily produced by the methods shown in [Reaction Formulas-1 and 2] below.

〔反応式−1〕 ([〕[1,) C式中、R1は前記と同じ意義を示す。〕すなわち、本
発明化合物〔■、〕は、化合物(mに3−ブロム−1−
ヨード−1−プロピン〔ジャーナル・オブ・ザ・アメリ
カン・ケミカル9ソサイエテ4 (Journal o
f the llwerican Chem−ical
 5ociety)、 77 @、 176 (195
5) )を反応させることにより製造することができる
。この反応は溶媒中塩基の存在下に行われる0本反応に
用いられる溶媒としては、例えばテトラヒドロフラン、
ジオキサン、アセトニトリル、N、N−ジメチルホルム
アミド等が好ましい、また、塩基としては、例えば水・
酸化カリウム、水酸化ナトリウム、水素化ナトリウム等
の無機塩基が好適である。
[Reaction formula-1] ([][1,) In formula C, R1 has the same meaning as above. ] That is, the compound of the present invention [■,] is a compound (3-bromo-1-
Iodo-1-propyne [Journal of the American Chemical Society 4 (Journal o
f the llwerican chemical
5ociety), 77 @, 176 (195
5) It can be produced by reacting . This reaction is carried out in the presence of a base in a solvent. Examples of solvents used in this reaction include tetrahydrofuran,
Dioxane, acetonitrile, N,N-dimethylformamide, etc. are preferable, and as the base, for example, water,
Inorganic bases such as potassium oxide, sodium hydroxide, sodium hydride and the like are preferred.

本反応は、−10〜100℃、とりわけ0℃〜室温下で
行うのがよい0反応時間は5分〜10時間、好ましくは
5分〜2時間である。化合物〔II〕と3−ブロム−1
−ヨード−1−プロピンの使用割合に関しては、通常前
者に対して後者を1〜1.5倍モル使用する。
This reaction is preferably carried out at -10 to 100°C, particularly from 0°C to room temperature, with a reaction time of 5 minutes to 10 hours, preferably 5 minutes to 2 hours. Compound [II] and 3-bromo-1
Regarding the usage ratio of -iodo-1-propyne, the latter is usually used in a molar range of 1 to 1.5 times that of the former.

(反応式−2〕 (11[]            [b’1〔式中、
“R2は前記と同じ意義を示す。〕また、上記本発明化
合物(Ib )は、化合物([1)に塩基の存在下、ヨ
ウ素を反応させることによって製造することができる。
(Reaction formula-2) (11 [] [b'1 [in the formula,
"R2 has the same meaning as above." Furthermore, the above-mentioned compound (Ib) of the present invention can be produced by reacting compound ([1) with iodine in the presence of a base.

塩基としては、例えば、水酸化カリウム、水酸化ナトリ
ウム等の無機塩基が挙げられる0反応は、通常、アルコ
ールと水の混合溶媒中で行われる。用いられるアルコー
ルとしては、例えばメタノール、エタノール、プロパツ
ール等が挙げられる0反応温度は0〜50℃、好ましく
はθ℃〜室温下において行われ、反応時間は2〜24時
間であるが、好ましくは2〜12時間である。化合物(
III )とヨウ素の使用割合に関しては、前者に対し
て後者を1〜1.5倍モル、好ましくは等モル使用する
のがよい。
Examples of the base include inorganic bases such as potassium hydroxide and sodium hydroxide. The reaction is usually carried out in a mixed solvent of alcohol and water. Examples of the alcohol used include methanol, ethanol, propatool, etc. The reaction temperature is 0 to 50°C, preferably θ°C to room temperature, and the reaction time is 2 to 24 hours, but preferably It is 2 to 12 hours. Compound(
Regarding the proportion of III) and iodine, it is preferable to use 1 to 1.5 times the mole of the former, preferably equimolar moles of the latter.

なお、前記〔反応式−1〕の化合物(II)は、例えば
、ベンゼン核に置換基R2(前記と同じ意義を示す)を
有する0−二トロフェノール誘導体とブロム酢酸エチル
を原料とし、ホンヵネン(トonkanen )等の方
法〔アクタ・ケミ力・スカンジナビ力(八cta Ch
emica 5candinavica )+  14
巻。
The compound (II) of [Reaction formula-1] can be prepared, for example, by using an 0-ditrophenol derivative having a substituent R2 (same meaning as above) on the benzene nucleus and ethyl bromoacetate as raw materials, and converting honkanene ( Methods such as acta, chemical forces, and Scandinavian forces (8 acta Ch.
emica 5candinavica)+14
roll.

1214 (1960))に準拠して得ることができる
1214 (1960)).

また、前記〔反応式−2〕の化合物(III )は、下
記反応式に従って容易に製造できる。
Moreover, the compound (III) of [Reaction formula-2] can be easily produced according to the following reaction formula.

(m             ’  (V)(III
 ) 〔式中、R1は前記と同じ意義を示す。〕化合物(IV
)と塩化クロルアセチルとの反応は特開昭49−125
529に記載の方法に準拠し、化合物(V)と3−ブロ
ムプロピンとの反応は前記〔反応式−1〕と同様な条件
下で行えばよい。
(m' (V) (III
) [In the formula, R1 has the same meaning as above. ] Compound (IV
) with chloroacetyl chloride is described in JP-A-49-125.
The reaction between compound (V) and 3-bromopropyne may be carried out under the same conditions as described in [Reaction Formula-1] above.

本発明化合物(1)は、強い抗真菌作用を示し、特に表
在性真菌症に対して有効である。したがって、通常、軟
膏剤、ゼリー剤、クリーム剤、粉末剤、溶液剤、乳液剤
あるいはスプレー剤等の外用製剤にして使用する。これ
らの製剤化に際し特に困難はなく、それぞれに適した賦
形剤を使用し、公知の方法に準拠して製剤化すればよい
、好ましい賦形剤としては、例えば、軟膏剤5ゼリー剤
及びクリーム剤の場合、動物性脂肪、植物性脂肪。
The compound (1) of the present invention exhibits a strong antifungal effect and is particularly effective against superficial mycoses. Therefore, it is usually used in the form of external preparations such as ointments, jellies, creams, powders, solutions, emulsions, or sprays. There is no particular difficulty in formulating these formulations, and they can be formulated according to known methods using excipients suitable for each. Preferred excipients include ointments, jelly formulations, and creams. In the case of pharmaceuticals, animal fats and vegetable fats.

ロウ、パラフィン、R粉トラガカント、セルロース誘導
体、ポリエチレングリコール、シリコーン。
Wax, paraffin, R powder tragacanth, cellulose derivatives, polyethylene glycol, silicone.

ベントナイト、シリカ、タルク、酸化亜鉛等が挙げられ
、粉末剤及びスプレー剤の場合、乳糖、タルク、シリカ
、水酸化アルミニウム、ケイ酸カルシウム、ポリアミド
粉末、噴射基剤としてのクロルフルオロ炭化水素等が挙
げられ、また、溶液剤及び乳液剤の場合は、水、エタノ
ール、イソプロピルアルコール、炭酸エチル、酢酸エチ
ル、ベンジルアルコール、ベンジルベンゾエート、プロ
ピレングリコール、1.3−ブチレングリコール。
Examples include bentonite, silica, talc, zinc oxide, etc., and in the case of powders and sprays, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, chlorofluorohydrocarbon as a propellant base, etc. In the case of solutions and emulsions, water, ethanol, isopropyl alcohol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol.

N、N−ジメチルホルムアミド、綿実油、南京豆油、ト
ウモロコシ油、オリーブ油、グリセリン。
N,N-dimethylformamide, cottonseed oil, bed bean oil, corn oil, olive oil, glycerin.

グリセリンホルマール、ポリエチレングリコール。Glycerin formal, polyethylene glycol.

ソルビトールの脂肪酸エステル等が挙げられる。Examples include fatty acid esters of sorbitol.

本発明化合物(1)の製剤中の濃度は、0. 1〜5重
量重量%間囲内が好ましい。
The concentration of the compound (1) of the present invention in the preparation is 0. A range of 1 to 5% by weight is preferred.

〔実施例1〕 4−ヒドロキシ−211−1,4−ベンズオキサジン−
3(4H)−オン5.3gと水酸イーカリウム2.1g
をN、N−ジメチルホルムアミド64−に加え、よくか
きまぜたのち氷冷攪拌下3−ブロムー1=ヨード−1−
プロピン9.4gを滴下した。室温にて2時間攪拌後、
・溶媒を減圧留去した。得られた残渣に水を加え、析出
した結晶を濾取し、クロロホルム−石油エーテルから再
結晶して4− (3−ヨード−2−プロピニルオキシ)
−2H−1,4−ベンズオキサジン−3(4H)−オン
5.2g(収率49%)を得た。融点122〜123℃
[Example 1] 4-hydroxy-211-1,4-benzoxazine-
5.3 g of 3(4H)-one and 2.1 g of e-potassium hydroxide
was added to N,N-dimethylformamide 64-, stirred well, and 3-bromo-1=iodo-1- was added to N,N-dimethylformamide 64-.
9.4 g of propyne was added dropwise. After stirring at room temperature for 2 hours,
- The solvent was distilled off under reduced pressure. Water was added to the resulting residue, the precipitated crystals were collected by filtration, and recrystallized from chloroform-petroleum ether to give 4-(3-iodo-2-propynyloxy).
5.2 g (yield 49%) of -2H-1,4-benzoxazin-3(4H)-one was obtained. Melting point 122-123℃
.

元素分析 : C++Hs  lNOsとして理論値(
χ) : C,40,15i 11.2.45 ; N
、 4.26実測値(χ) : C,40,58i H
,2,70; N、 4.03I Ru Q9” cv
*−’ : 2180(C=C)、 1665(C−0
)N M R(DMSO−di)δ: 4.75 (2
H,s、0−CHz−GO)。
Elemental analysis: Theoretical value as C++Hs lNOs (
χ): C, 40, 15i 11.2.45; N
, 4.26 Actual value (χ): C, 40, 58i H
,2,70; N, 4.03I Ru Q9” cv
*-': 2180 (C=C), 1665 (C-0
)NMR(DMSO-di)δ: 4.75 (2
H, s, 0-CHz-GO).

4.95 (2H,s、o−CHg−Cs*C)+ 6
.96〜7.30 (4tl、*、Ar−omatic
−H) Mass (m/z):329 (M”)〔実施例2〕 8−クロル−4−ヒドロキシ−28−1,4−ベンズオ
キサジン−3(4H)−オン3.7gと3−ブロム−1
−ヨード−1−プロピン5.4gとを実施例1と同様に
反応させ、処理して8−クロル−4−(3−ヨード−2
−プロピニルオキシ)−2H−1,4−ベンズオキサジ
ン−3(4H)−オン4.5g (収率74%)を得た
。融点148〜150℃。
4.95 (2H,s,o-CHg-Cs*C)+6
.. 96~7.30 (4tl, *, Ar-omatic
-H) Mass (m/z): 329 (M”) [Example 2] 3.7 g of 8-chloro-4-hydroxy-28-1,4-benzoxazin-3(4H)-one and 3-bromine -1
-Iodo-1-propyne (5.4 g) was reacted in the same manner as in Example 1, and treated with 8-chloro-4-(3-iodo-2-propylene).
4.5 g (yield: 74%) of -propynyloxy)-2H-1,4-benzoxazin-3(4H)-one was obtained. Melting point: 148-150°C.

元素分析 : C++H?CI I NOxとして理論
値(χ) : C,36,34; H,1,97; N
、 3.85実測値(χ) : C,36,39; H
,1,99; N、 3.86IRν易l朱”  cm
−’  : 2180(C=C)、  1680(C−
0)N M R([1M5O−di)δ : 4.90
  (2H,s、0−C11t−Co)。
Elemental analysis: C++H? Theoretical value (χ) for CI I NOx: C, 36,34; H, 1,97; N
, 3.85 Actual value (χ): C, 36, 39; H
, 1,99;
-': 2180 (C=C), 1680 (C-
0)NMR([1M5O-di)δ: 4.90
(2H,s,0-C11t-Co).

4.97 (2H,3,0−CI+!−C=C)、 7
.20〜7.’30 (3H,n+、^r−omati
c−II) Mass  (m/z)  :363  (M”)〔実
施例3〕 4−(2−プロピニル)−2H−1,4−ベンズオキサ
ジン−3(4H)−オン30gをメタノール320sd
と5N水酸化す) IJウム水溶液32−の混合溶液に
懸濁し、水冷撹拌下ヨウ素4067gを加えた。その後
室温にて12時間攪拌した。
4.97 (2H,3,0-CI+!-C=C), 7
.. 20-7. '30 (3H, n+, ^r-omati
c-II) Mass (m/z): 363 (M”) [Example 3] 30 g of 4-(2-propynyl)-2H-1,4-benzoxazin-3(4H)-one in 320 sd of methanol
and 5N hydroxide) was suspended in a mixed solution of 32% of an aqueous solution of iodine, and 4067 g of iodine was added thereto while stirring while cooling with water. Thereafter, the mixture was stirred at room temperature for 12 hours.

反応液を水中に注ぎクロロホルムで抽出した。抽出液を
チオ硫酸ナトリウム水溶液で洗浄、乾燥後溶媒を留去し
た。得られた結晶をクロロホルム−石油エーテルから・
再結晶して4−(3−ヨード−2−プロピニル)−2H
−1,4−ベンズオキサジン−3(4H)−オン20.
9g(収率42%)を得た。融点166〜171℃、′ 元素分析 : C++Hs  t Notとして理論値
(χ) : C,42,20i H,2゜58 ; N
、 4.47実測値(χ) : C,42,03、H,
2,6B 、 N、 4.27I Rv:gQ” c+
w−’ : 2180(CミC)、  1655(C=
O)N M R(DMSO−da)δ : 4.63 
 (2H,s、0−CHt−CO)。
The reaction solution was poured into water and extracted with chloroform. The extract was washed with an aqueous sodium thiosulfate solution, dried, and then the solvent was distilled off. The obtained crystals were separated from chloroform-petroleum ether.
Recrystallize to give 4-(3-iodo-2-propynyl)-2H
-1,4-benzoxazin-3(4H)-one 20.
9 g (yield 42%) was obtained. Melting point 166-171℃,' Elemental analysis: C++Hs t Not theoretical value (χ): C, 42,20i H, 2゜58; N
, 4.47 Actual value (χ): C, 42,03, H,
2,6B, N, 4.27I Rv:gQ"c+
w-': 2180 (CmiC), 1655 (C=
O)NMR(DMSO-da)δ: 4.63
(2H,s,0-CHt-CO).

4.80  (211,s、O−C0−C1lミC)1
6.96〜7.28  (48,m、八r−omati
c−H) Ma s s  (m/ z)  :  3 13  
(M’ )〔実施例4〜15〕 対応原料化合物を実施例3と同様に処理して下記化合物
を得た。
4.80 (211,s, O-C0-C1lmiC)1
6.96~7.28 (48, m, 8 r-omati
c-H) Mas s (m/z): 3 13
(M') [Examples 4 to 15] The corresponding raw material compounds were treated in the same manner as in Example 3 to obtain the following compounds.

〔参考例1〕 (a)N、N−ジメチルホルムアミド400adにO−
ニトロフェノール69.5g、ブロム酢酸エチル125
g及び炭酸カリウム104gを加え、80℃で2時間攪
拌したのち冷却した。不溶物を濾去後溶媒を減圧留去し
、残渣に水を加えクロロホルムで抽出した。抽出液を水
洗、乾燥後溶媒を留去し、さらに減圧薫留して0−ニト
ロフェノキシ酢酸エチル96g(収率85%)を得た。
[Reference Example 1] (a) O- to N,N-dimethylformamide 400ad
Nitrophenol 69.5g, ethyl bromoacetate 125g
g and 104 g of potassium carbonate were added thereto, stirred at 80° C. for 2 hours, and then cooled. After filtering off the insoluble matter, the solvent was distilled off under reduced pressure, water was added to the residue, and the mixture was extracted with chloroform. After washing the extract with water and drying, the solvent was distilled off and further vacuum distilled to obtain 96 g of ethyl 0-nitrophenoxyacetate (yield: 85%).

沸点145〜146℃10.3mmHg。Boiling point: 145-146°C, 10.3 mmHg.

(b)o−ニトロフェノキシ酢酸エチル22.5g、エ
タノール10〇−及び亜鉛粉末15.2gを混合し、室
温にて攪拌しながら塩化アンモニウム6.2gを含む水
溶液20−を滴下した0滴下後さらに3時間攪拌したの
ち水冷下2.4N塩酸200mを滴下した。不溶物を濾
取し、エタノールから再結晶して4−ヒドロキシ−2H
−1,4−ベンズオキサジン−3(4H)−オン6.2
g (収率38%)を得た。融点168〜171℃。
(b) 22.5 g of ethyl o-nitrophenoxyacetate, 100 g of ethanol, and 15.2 g of zinc powder were mixed, and 20 g of an aqueous solution containing 6.2 g of ammonium chloride was added dropwise while stirring at room temperature. After stirring for 3 hours, 200 ml of 2.4N hydrochloric acid was added dropwise while cooling with water. Insoluble materials were collected by filtration and recrystallized from ethanol to give 4-hydroxy-2H.
-1,4-benzoxazin-3(4H)-one 6.2
g (yield 38%) was obtained. Melting point 168-171°C.

〔参考例2〕 6−クロル−2−二トロフェノール及びブロム酢酸エチ
ルを原料として使用し、参考例1と同様に処理して8−
クロル−4−ヒドロキシ−2H−1,4−ベンズオキサ
ジン−3(4H)−オンを58%の収率で得た。融点2
23〜225℃。
[Reference Example 2] Using 6-chloro-2-nitrophenol and ethyl bromoacetate as raw materials, the same procedure as in Reference Example 1 was used to obtain 8-
Chlor-4-hydroxy-2H-1,4-benzoxazin-3(4H)-one was obtained with a yield of 58%. Melting point 2
23-225°C.

〔参考例3〕 (a)o−アミノフェノールl1g、)リエチルアミン
15.5g及び酢酸エチル500−の混合溶液に、水冷
下、塩化クロルアセチル11.3gを滴下した。室温に
て2時間攪拌したのち反応液を水洗し、溶媒を留去した
。残渣に0.3N水酸化ナトリウム水溶液5(ladを
加え、80℃にて加熱熔解させ、析出した結晶をベンゼ
ンから再結晶して2H−1,4−ベンズオキサジン−3
(4H)−オン5.6g(収率38%)を得た。 融点
177〜178℃。
[Reference Example 3] To a mixed solution of (a) 1 g of o-aminophenol, 15.5 g of ethylamine, and 500 g of ethyl acetate, 11.3 g of chloroacetyl chloride was added dropwise under water cooling. After stirring at room temperature for 2 hours, the reaction solution was washed with water and the solvent was distilled off. A 0.3N aqueous sodium hydroxide solution 5 (lad) was added to the residue, heated and melted at 80°C, and the precipitated crystals were recrystallized from benzene to give 2H-1,4-benzoxazine-3.
5.6 g (yield 38%) of (4H)-one was obtained. Melting point: 177-178°C.

(b)2H−1,4−ベンズオキサジン−3(4H)−
オン4.5g、水酸化カリウム2.0g及びN、N−ジ
メチルホルムアミド60−の混合物を室温にて1時間攪
拌したのち、水冷下3−ブロムプロピン7.1gを滴下
した。室温下さらに1時間攪拌し、溶媒を減圧留去後得
られた残渣に水を加え析出した結晶を濾取した。N、N
−ジメチルホルムアミド−イソプロピルエーテルから再
結晶して4−(2−プロピニル)−2H−1,4−ベン
ズオキサジン−3(4H)−オン 2.1g(収率37
%)を得た。融点123〜125℃。
(b) 2H-1,4-benzoxazine-3(4H)-
After stirring a mixture of 4.5 g of onion, 2.0 g of potassium hydroxide, and 60 g of N,N-dimethylformamide at room temperature for 1 hour, 7.1 g of 3-bromopropyne was added dropwise while cooling with water. The mixture was further stirred at room temperature for 1 hour, and the solvent was distilled off under reduced pressure. Water was added to the resulting residue, and the precipitated crystals were collected by filtration. N, N
Recrystallization from -dimethylformamide-isopropyl ether gave 2.1 g of 4-(2-propynyl)-2H-1,4-benzoxazin-3(4H)-one (yield: 37
%) was obtained. Melting point 123-125°C.

〔参考例4〜15〕 対応原料化合物を参考例3と同様に処理して下記化合物
を得た。
[Reference Examples 4 to 15] The corresponding raw material compounds were treated in the same manner as in Reference Example 3 to obtain the following compounds.

第  2  表 cHzc=cH 〔製剤例〕 実施例1の化合物       2.0g白色ワセリン
        25.0gステアリルアルコール  
  25.0gプロピレングリコール    12.0
gラウリル硫酸ナトリウム    1.5gバラオキシ
安息香酸エチル   0.5gさらに脱イオン水を加え
て全量を100.0gとする。
Table 2 cHzc=cH [Formulation example] Compound of Example 1 2.0g white petrolatum 25.0g stearyl alcohol
25.0g Propylene glycol 12.0
g Sodium lauryl sulfate 1.5 g Ethyl oxybenzoate 0.5 g Further, add deionized water to bring the total amount to 100.0 g.

上記混合物を常法に従って均一に混合し、クリーム剤と
した。
The above mixture was uniformly mixed according to a conventional method to prepare a cream.

〔生物試験〕[Biological test]

(1)各種真菌に対する最小発育阻止濃度(MIC)の
測定 サブローデキストロース培地を用い、日本化学療法学会
標準法(’1980年改訂)に準じて寒天平板希釈法に
よりMICを求めた。その結果を第3表に示す。
(1) Measurement of Minimum Inhibitory Concentration (MIC) for Various Fungi Using Sabouraud dextrose medium, MIC was determined by the agar plate dilution method according to the standard method of the Japanese Society of Chemotherapy (revised in 1980). The results are shown in Table 3.

第3表     MIC(μg/−) a)(1):カンジダ・アルビカンス(Candida
albicans )  I F O1060、(II
) :カンジダ・トロピカーリス(Candida t
ropicalis )IFO1633、(III) 
j  )リコフィートン・ルブラム(Trichoph
yton rubru+w) T R−37、(m :
アースロデルマ・パンブロイゼゲミー(Arthrod
ersa vanbreuseghes+ii) S 
M 7420、(V):  ミクロスポーラム・キャニ
ス(Micro−sporum cants) SM 
8333 As b)試験せず。
Table 3 MIC (μg/-) a) (1): Candida albicans (Candida albicans)
albicans) I F O1060, (II
): Candida tropicalis (Candida t
ropicalis) IFO1633, (III)
j) Trichophyton Rubrum (Trichoph)
yton rubru+w) TR-37, (m:
Arthroderma pambrosegemie (Arthrod)
ersa vanbreuseghes+ii) S
M 7420, (V): Micro-sporum cants SM
8333 As b) Not tested.

(2)急性毒性試験 被検化合物を0.5%カルボキシメチルセルロース溶液
に懸濁し、体重20〜25gのDDY系雄性マウス(1
群lO匹)に経口投与して、投与後7日間の累積死亡率
から50%致死量(LDs。)を算出した。結果を第4
表に示す。
(2) Acute toxicity test The test compound was suspended in 0.5% carboxymethyl cellulose solution, and DDY male mice weighing 20-25 g (1
The 50% lethal dose (LDs.) was calculated from the cumulative mortality rate for 7 days after administration. 4th result
Shown in the table.

第4表 (発明の効果〕 本発明化合物は各種真菌に対するMIC測定実験におい
て優れた活性を示し、また、動物実験において毒性が低
いことが確認された。
Table 4 (Effects of the Invention) The compounds of the present invention showed excellent activity in MIC measurement experiments against various fungi, and were also confirmed to have low toxicity in animal experiments.

本発明化合物は、抗真凹薬として優れた効果を特徴するThe compound of the present invention is characterized by excellent effects as an anti-depressant drug.

Claims (3)

【特許請求の範囲】[Claims] (1)一般式〔 I 〕 ▲数式、化学式、表等があります▼〔 I 〕 〔式中、R^1は3−ヨード−2−プロピニルオキシ基
又は3−ヨード−2−プロピニル基を示す。 R^2は水素原子、ハロゲン原子、低級アルキル基、ア
シルオキシ基又はニトロ基を示す。〕で表される2H−
1,4−ベンズオキサンソ−3(4H)−オン誘導体。
(1) General formula [I] ▲Mathematical formulas, chemical formulas, tables, etc.▼[I] [In the formula, R^1 represents a 3-iodo-2-propynyloxy group or a 3-iodo-2-propynyl group. R^2 represents a hydrogen atom, a halogen atom, a lower alkyl group, an acyloxy group, or a nitro group. ] 2H-
1,4-benzoxanth-3(4H)-one derivative.
(2)一般式〔 I 〕において、R^1が3−ヨード−
2−プロピニルオキシ基で表される特許請求の範囲第1
項記載の化合物。
(2) In the general formula [I], R^1 is 3-iodo-
Claim 1 represented by 2-propynyloxy group
Compounds described in Section.
(3)一般式〔 I 〕において、R^1が3−ヨード−
2−プロピニル基で表される特許請求の範囲第1項記載
の化合物。
(3) In the general formula [I], R^1 is 3-iodo-
The compound according to claim 1, which is represented by a 2-propynyl group.
JP1437987A 1987-01-23 1987-01-23 2h-1,4-benzoxazin-3(4h)-one derivative Pending JPS63185970A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1437987A JPS63185970A (en) 1987-01-23 1987-01-23 2h-1,4-benzoxazin-3(4h)-one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1437987A JPS63185970A (en) 1987-01-23 1987-01-23 2h-1,4-benzoxazin-3(4h)-one derivative

Publications (1)

Publication Number Publication Date
JPS63185970A true JPS63185970A (en) 1988-08-01

Family

ID=11859409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1437987A Pending JPS63185970A (en) 1987-01-23 1987-01-23 2h-1,4-benzoxazin-3(4h)-one derivative

Country Status (1)

Country Link
JP (1) JPS63185970A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008012385A1 (en) 2006-07-28 2008-01-31 Universidad De Cádiz Phytotoxic halogenated derivatives of benzoxazinones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008012385A1 (en) 2006-07-28 2008-01-31 Universidad De Cádiz Phytotoxic halogenated derivatives of benzoxazinones

Similar Documents

Publication Publication Date Title
HU194839B (en) Process for production of derivatives of triasole and imidasole and medical preparatives containing such compounds
LU85245A1 (en) NOVEL AZOLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIFUNGALS AND FUNGICIDES
EP0243904A1 (en) Optionally substituted 1-(2&#39;-[bis-(phenyl)-methoxy]-ethyl)-4-(3&#39;[bis-(phenyl)-methoxy]propyl)piperazines, process for their preparation and medicines containing them
JPS6033818B2 (en) Manufacturing method for new naphthalene derivatives
EP0010361B1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
EP0490816B1 (en) Fluoro-compounds and their use as aromatase inhibitors
JPH01294670A (en) 2-(piperadinyl)-2-oxoethylene-substituted flavonoid derivative, its production and pharmaceutical composition containing said derivative
EP0006789A1 (en) Bis(aryloxy-alcanecarboxylic compounds, their preparation and their therapeutic use
HU195502B (en) Process for producing triazol derivatives of fungicide activity and pharmaceutical compositions containing them
JPS63185970A (en) 2h-1,4-benzoxazin-3(4h)-one derivative
PL103682B1 (en) METHOD OF MAKING NEW DERIVATIVES OF INDAZOLYLOXY-4-PROPANOLOAMINE
US3418355A (en) Didecyl quaternary ammonium compounds
JPS62281860A (en) Dihydro-3,5-dicarboxylate having alkyleneaminoalkyleneheteroatomic group
KR970011395B1 (en) Enol ethers of 6-chloro-4-hydroxy-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1.2-thiazine-3-carboxamide 1,1-dioxide
JPS6344749B2 (en)
JPH0288566A (en) Diphenylethane derivative, its production, and aromatase inhibiting drug and veterinary composition containing the same
DD146823A5 (en) PROCESS FOR PREPARING AMINO-PROPANOL DERIVATIVES OF 6-HYDROXY-2,3,4,5-TETRAHYDRO-1 H-1-BENZAZEPIN-2-ONE
EP0000693A1 (en) Aminophenoxymethyl-2-morpholine derivatives, the preparation thereof and pharmaceuticals containing them
JPH0372221B2 (en)
JPH0353314B2 (en)
EP0182271B1 (en) Nb-quaternary dibromo derivatives of ajmaline, isoajmaline, sandwicine and isosandwicine, pharmaceutical compositions containing them, intermediates and process for their preparation
HU209302B (en) Method for producing dihydro-benzo-(b)-thiphenes and pharmaceutical preparatives containing these compounds
HU189439B (en) Process for producing triazol compounds
EP0647221A1 (en) 1-aryl(4-o-alkoxyphenyl 1-piperazinyl)-2, -3 or -4 alkanols, process for their preparation and use thereof in the preparation of drugs
JPS59128326A (en) Antieumycetic agent